Jean-Michel Molina, St-Louis Hospital and University

St-Louis Hospital and University
Jean-Michel Molina, is Professor of Infectious Diseases at the University of Paris, and Head of the ID Department at the Saint-Louis Hospital in Paris, France. Prof. Molina's primary clinical research interest focuses initially on the treatment of AIDS-related opportunistic infections, and then the treatment of HIV infection. A cohort of more than 6,000 patients with HIV infection is followed in his department. He is a member of the INSERM U944 team at the Saint-Louis Hospital investigating cell biology of viral infections. Prof. Molina is also involved in the French National Agency for AIDS Research (ANRS), where he chaired the clinical trial group for the last 12 years before becoming a member of the strategic committee. More recently, Prof. Molina has broadened his field of interest to the prevention of HIV infection and has led the ANRS IPERGAY PrEP trial in men who have sex with men. A cohort of more than 2,800 persons is followed on PrEP in the department

Presenter Of 3 Presentations

Non-Commercial Satellite

STI in the era of PrEP and U=U: Can increased screening, STI PEP, and other approaches result in limiting spread?

Organizer
International AIDS Society; World Health Organization
Room
Satellite Channel 4
Non-Commercial Satellite

Panel (Part 2): Why offering ED-PrEP matters, how to accelerate access to ED-PrEP, and where the science is headed!

Presenter Of 1 Presentation

Bridging session

Conclusion

Room
Symposia and bridging sessions On-Demand Channel

Moderator Of 1 Session

Bridging session
Room
Symposia and bridging sessions On-Demand Channel
Session Description
This session will address the worsening global epidemic of STIs and the interface with the expansion of HIV treatment and prevention, including emerging strategies in diagnosis and prevention. Exciting new research in STI testing, treatment, partner treatment and prevention relevant globally will be highlighted. It will also include a debate on whether to use doxycycline post-exposure prophylaxis for STI prevention, and the benefits and potential risks. CHAR(13) + CHAR(10)

Presenter Of 1 Presentation

Bridging session

Conclusion

Room
Symposia and bridging sessions On-Demand Channel

Moderator Of 1 Session

Bridging session
Room
Symposia and bridging sessions On-Demand Channel
Session Description
This session will address the worsening global epidemic of STIs and the interface with the expansion of HIV treatment and prevention, including emerging strategies in diagnosis and prevention. Exciting new research in STI testing, treatment, partner treatment and prevention relevant globally will be highlighted. It will also include a debate on whether to use doxycycline post-exposure prophylaxis for STI prevention, and the benefits and potential risks. CHAR(13) + CHAR(10)

Presenter Of 4 Presentations

Non-Commercial Satellite

Panel (Part 2): Why offering ED-PrEP matters, how to accelerate access to ED-PrEP, and where the science is headed!

Bridging session

Conclusion

Room
Symposia and bridging sessions On-Demand Channel
Non-Commercial Satellite

STI in the era of PrEP and U=U: Can increased screening, STI PEP, and other approaches result in limiting spread?

Organizer
International AIDS Society; World Health Organization
Room
Satellite Channel 4

Moderator Of 1 Session

Bridging session
Room
Symposia and bridging sessions On-Demand Channel
Session Description
This session will address the worsening global epidemic of STIs and the interface with the expansion of HIV treatment and prevention, including emerging strategies in diagnosis and prevention. Exciting new research in STI testing, treatment, partner treatment and prevention relevant globally will be highlighted. It will also include a debate on whether to use doxycycline post-exposure prophylaxis for STI prevention, and the benefits and potential risks. CHAR(13) + CHAR(10)